3B Blackbio, a company in the Healthcare Service Provider industry, reported revenue of ₹48 crore and net profit of ₹18 crore for the September 2026 quarter.
3B Blackbio (NSE: 3BBLACKBIO) closed at ₹1,305.10 on 20 Nov 2026. Its market capitalisation is ₹1,120 crore and it trades at 19.1 times earnings.
Incorporated in 2011, 3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.